BioCentury | Mar 17, 2014
Company News

Medinet, TC Biopharm deal

...TC Biopharm acquired an exclusive, European license to Medinet's cell processing technology. TC Biopharm will use...
...and that it plans to start a Phase II trial in melanoma in early 2015. Medinet...
...Biopharm also received a £500,000 ($835,400) award from Scottish Enterprise, a Scottish economic development agency. Medinet Co. Ltd....
BioCentury | Mar 17, 2014
Financial News

TC Biopharm completes venture financing

...Midlothian, U.K. Business: Cancer Date completed: 3/11/14 Type: Venture financing Raised: Not disclosed Investors: MediNet...
BioCentury | Feb 11, 2013
Finance

Bubbling up in Japan

...Ltd. (Osaka:4552) ¥1,611 ¥640-¥1,827 70% 26% $564.1 MediBIC Group (Tokyo:2369) ¥92 ¥46-¥179 81% -4% $24.5 Medinet Co. Ltd....
BioCentury | Feb 1, 2012
Financial News

Regimmune raises $5 million as RGI-2001 enters Phase I/II

...Enterprise Co. Ltd. and Japan Asia Investment Corp. (JAIC). Other investors included Shinkin Capital Corp.; MediNet Co. Ltd....
BioCentury | Nov 16, 2009
Company News

Medinet, NanoCarrier deal

...cell therapies which use effector cells and antigen presenting cells. Further details were not disclosed. Medinet Co. Ltd....
BioCentury | Sep 3, 2007
Company News

MaxCyte, Medinet deal

...to support clinical studies of Medinet's preclinical cell therapy to treat cancer and to commercialize Medinet's...
...see BioCentury, Aug. 21, 2006). Financial terms were not disclosed. MaxCyte Inc. , Rockville, Md. Medinet Co. Ltd....
BioCentury | Aug 21, 2006
Company News

MaxCyte, Medinet deal

...and to commercialize Medinet's product. Further terms were not disclosed. MaxCyte Inc. , Rockville, Md. Medinet Co. Ltd....
BioCentury | Feb 14, 2005
Finance

Japanese IPOs

...44% -53% 3/04 $6 $86 Medibic (Tokyo:2369) Genomics database ¥141,000 -51% -46% 9/03 $21 $107 Medinet...
BioCentury | Aug 30, 2004
Finance

Ebb & Flow

...DNA Chip , which provides DNA chips and cDNA services; cell therapy services provider Medinet...
...and genomics database play Medibic - are down about 30%. In fact, DNA Chip and Medinet...
BioCentury | Jul 26, 2004
Finance

Japanese IPOs

...animal services 12/02 $25 $107 $98 -9% Medibic Genomics database 9/03 $21 $107 $84 -21% Medinet...
Items per page:
1 - 10 of 10
BioCentury | Mar 17, 2014
Company News

Medinet, TC Biopharm deal

...TC Biopharm acquired an exclusive, European license to Medinet's cell processing technology. TC Biopharm will use...
...and that it plans to start a Phase II trial in melanoma in early 2015. Medinet...
...Biopharm also received a £500,000 ($835,400) award from Scottish Enterprise, a Scottish economic development agency. Medinet Co. Ltd....
BioCentury | Mar 17, 2014
Financial News

TC Biopharm completes venture financing

...Midlothian, U.K. Business: Cancer Date completed: 3/11/14 Type: Venture financing Raised: Not disclosed Investors: MediNet...
BioCentury | Feb 11, 2013
Finance

Bubbling up in Japan

...Ltd. (Osaka:4552) ¥1,611 ¥640-¥1,827 70% 26% $564.1 MediBIC Group (Tokyo:2369) ¥92 ¥46-¥179 81% -4% $24.5 Medinet Co. Ltd....
BioCentury | Feb 1, 2012
Financial News

Regimmune raises $5 million as RGI-2001 enters Phase I/II

...Enterprise Co. Ltd. and Japan Asia Investment Corp. (JAIC). Other investors included Shinkin Capital Corp.; MediNet Co. Ltd....
BioCentury | Nov 16, 2009
Company News

Medinet, NanoCarrier deal

...cell therapies which use effector cells and antigen presenting cells. Further details were not disclosed. Medinet Co. Ltd....
BioCentury | Sep 3, 2007
Company News

MaxCyte, Medinet deal

...to support clinical studies of Medinet's preclinical cell therapy to treat cancer and to commercialize Medinet's...
...see BioCentury, Aug. 21, 2006). Financial terms were not disclosed. MaxCyte Inc. , Rockville, Md. Medinet Co. Ltd....
BioCentury | Aug 21, 2006
Company News

MaxCyte, Medinet deal

...and to commercialize Medinet's product. Further terms were not disclosed. MaxCyte Inc. , Rockville, Md. Medinet Co. Ltd....
BioCentury | Feb 14, 2005
Finance

Japanese IPOs

...44% -53% 3/04 $6 $86 Medibic (Tokyo:2369) Genomics database ¥141,000 -51% -46% 9/03 $21 $107 Medinet...
BioCentury | Aug 30, 2004
Finance

Ebb & Flow

...DNA Chip , which provides DNA chips and cDNA services; cell therapy services provider Medinet...
...and genomics database play Medibic - are down about 30%. In fact, DNA Chip and Medinet...
BioCentury | Jul 26, 2004
Finance

Japanese IPOs

...animal services 12/02 $25 $107 $98 -9% Medibic Genomics database 9/03 $21 $107 $84 -21% Medinet...
Items per page:
1 - 10 of 10